BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Farina N, Ramirez GA, De Lorenzo R, Di Filippo L, Conte C, Ciceri F, Manfredi AA, Rovere-Querini P. COVID-19: Pharmacology and kinetics of viral clearance. Pharmacol Res 2020;161:105114. [PMID: 32758635 DOI: 10.1016/j.phrs.2020.105114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 De Lorenzo R, Sciorati C, Lorè NI, Capobianco A, Tresoldi C, Cirillo DM, Ciceri F, Rovere-Querini P, Manfredi AA. Chitinase-3-like protein-1 at hospital admission predicts COVID-19 outcome: a prospective cohort study. Sci Rep 2022;12:7606. [PMID: 35534648 DOI: 10.1038/s41598-022-11532-x] [Reference Citation Analysis]
2 Cavalli G, Farina N, Campochiaro C, Baldissera E, Dagna L. Current treatment options and safety considerations when treating adult-onset Still's disease. Expert Opin Drug Saf 2020;19:1549-58. [PMID: 33078630 DOI: 10.1080/14740338.2020.1839411] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Farina N, Dagna L. Interleukin 6 inhibition in severe COVID-19: another piece of the puzzle. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.04.018] [Reference Citation Analysis]
4 Di Pierro F, Iqtadar S, Khan A, Ullah Mumtaz S, Masud Chaudhry M, Bertuccioli A, Derosa G, Maffioli P, Togni S, Riva A, Allegrini P, Khan S. Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial. Int J Gen Med 2021;14:2807-16. [PMID: 34194240 DOI: 10.2147/IJGM.S318949] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Kumari K, Chainy GBN, Subudhi U. Prospective role of thyroid disorders in monitoring COVID-19 pandemic. Heliyon 2020;6:e05712. [PMID: 33344794 DOI: 10.1016/j.heliyon.2020.e05712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Isidori AM, Marcelli M, Castagna MG, Baldassarri M, Fava F, Renieri A. In response to the letter to the editor by Soha Ghanian et al. re our publication "Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males". EBioMedicine 2021;68:103426. [PMID: 34134089 DOI: 10.1016/j.ebiom.2021.103426] [Reference Citation Analysis]
7 Cavalli G, Farina N, Campochiaro C, De Luca G, Della-Torre E, Tomelleri A, Dagna L. Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic. Front Pharmacol 2020;11:598308. [PMID: 33442386 DOI: 10.3389/fphar.2020.598308] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
8 Gherlone EF, Polizzi E, Tetè G, De Lorenzo R, Magnaghi C, Rovere Querini P, Ciceri F. Frequent and Persistent Salivary Gland Ectasia and Oral Disease After COVID-19. J Dent Res 2021;100:464-71. [PMID: 33655804 DOI: 10.1177/0022034521997112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
9 Al Sulaiman KA, Aljuhani O, Eljaaly K, Alharbi AA, Al Shabasy AM, Alsaeedi AS, Al Mutairi M, Badreldin HA, Al Harbi SA, Al Haji HA, Al Zumai OI, Vishwakarma RK, Alkatheri A. Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study. Int J Infect Dis 2021;105:180-7. [PMID: 33601030 DOI: 10.1016/j.ijid.2021.02.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
10 Farina N, Benanti G, De Luca G, Palmisano A, Peretto G, Tomassetti S, Giorgione V, Forma O, Esposito A, Danese S, Dagna L, Matucci-cerinic M, Campochiaro C. The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis. JMDH 2022;Volume 15:815-24. [DOI: 10.2147/jmdh.s295478] [Reference Citation Analysis]
11 Lorè NI, De Lorenzo R, Rancoita PMV, Cugnata F, Agresti A, Benedetti F, Bianchi ME, Bonini C, Capobianco A, Conte C, Corti A, Furlan R, Mantegani P, Maugeri N, Sciorati C, Saliu F, Silvestri L, Tresoldi C, Ciceri F, Rovere-Querini P, Di Serio C, Cirillo DM, Manfredi AA; Bio Angels for COVID-BioB Study Group. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study. Mol Med 2021;27:129. [PMID: 34663207 DOI: 10.1186/s10020-021-00390-4] [Reference Citation Analysis]